Starbucks
SBUX
$99.54
+0.02%
Starbucks Corp is the world's largest and most recognizable coffee brand, operating a global network of nearly 41,000 company-operated and licensed cafes across over 80 countries, with its core business centered on ultracustomizable beverages, food, and packaged coffee products. The company is a dominant market leader in the global restaurant industry, distinguished by its powerful brand, massive scale, and a dual revenue model split between company-operated stores and a high-margin licensing business. The current investor narrative is intensely focused on the company's ongoing turnaround story, which is pressuring near-term profitability due to high costs, and the sustainability of its long-standing dividend growth streak amidst concerns over cash flow and payout ratios, as highlighted by recent news discussing the 'high costs of its turnaround' and a 'dividend at a crossroads'.…
SBUX
Starbucks
$99.54
Related headlines
Investment Opinion: Should I buy SBUX Today?
Rating: Hold. The core thesis is that Starbucks is a high-quality brand undergoing a costly operational turnaround, with the stock fairly valuing the recovery scenario but carrying significant execution risk and near-term financial strain.
The recommendation is supported by a forward P/E of 33.99x, which prices in a substantial earnings rebound but remains at a premium to peers. Revenue growth, while positive at 5.43% YoY, is decelerating. Profitability metrics are deeply concerning, with gross margin at 15.63%. However, strong TTM free cash flow of $2.34 billion provides a critical lifeline. The mixed analyst sentiment, with recent actions including a downgrade alongside reiterations, reflects this cautious, wait-and-see environment.
The thesis would upgrade to a Buy if evidence emerges that gross margins are stabilizing above 20% and the dividend coverage improves, signaling turnaround success. It would downgrade to a Sell if revenue growth turns negative or liquidity further deteriorates (current ratio below 0.6). Relative to its own history and the sector, the stock is fairly valued for the recovery it must deliver, but is overvalued if the turnaround falters.
Sign up to view all
SBUX 12-Month Price Forecast
The outlook is one of cautious neutrality. The stock's premium valuation already reflects a successful turnaround, leaving limited near-term upside without flawless execution. The substantial free cash flow is a key strength, but it is being overshadowed by severe margin pressure and dividend sustainability concerns. The base case of gradual, volatile progress is most likely. The stance would upgrade to bullish on clear evidence of margin stabilization and would turn bearish on a dividend cut or further significant deterioration in liquidity.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Starbucks's 12-month outlook, with a consensus price target around $129.40 and implied upside of +30.0% versus the current price.
Average Target
$129.40
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$80 - $129
Analyst target range
Analyst coverage for Starbucks is limited, with only 5 analysts providing estimates, which is unusually low for a company of its size and suggests a potential gap in institutional research coverage that can lead to higher volatility and less efficient price discovery. The available analyst data points to an average estimated EPS of $4.27 for the coming period, with a range from $4.03 to $4.42, and an average estimated revenue of $44.64 billion, implying a forward revenue growth expectation; however, without a consensus price target or recommendation distribution, the implied market sentiment cannot be quantitatively assessed from this dataset alone. The recent institutional ratings show a mixed but generally stable picture, with actions in Q1 2026 including one downgrade (RBC Capital from Outperform to Sector Perform) alongside several reiterations of Buy, Overweight, and Hold ratings, indicating analysts are cautiously monitoring the turnaround's progress without a strong directional consensus shift.
Bulls vs Bears: SBUX Investment Factors
The investment debate for Starbucks centers on a high-stakes turnaround story. The bear case, supported by severe margin compression, an unsustainable dividend, and a strained balance sheet, currently presents stronger near-term evidence. However, the bull case rests on the company's formidable brand, scale, robust cash flow, and the market's expectation of an earnings recovery. The single most important tension is the sustainability of the dividend amidst the profitability crunch. If management can successfully execute the turnaround and restore margins without cutting the dividend, the stock could re-rate higher. Conversely, a dividend cut or further earnings disappointment would likely trigger significant downside.
Bullish
- Strong Free Cash Flow Generation: Despite earnings pressure, the company generated $2.34 billion in trailing twelve-month free cash flow, providing a crucial buffer to fund its turnaround and maintain its dividend. This robust cash generation underpins the company's financial resilience and ability to invest in growth initiatives.
- Powerful Brand & Global Scale: Starbucks operates nearly 41,000 stores globally, making it the world's largest coffee brand with a dominant market position. This massive scale and powerful brand recognition provide a significant competitive moat and a stable revenue base, with 74% of revenue coming from the mature North American market.
- Technical Momentum & Recovery: The stock is in a sustained uptrend, gaining 22.70% over the past year and 7.92% in the last month, significantly outperforming the S&P 500. Trading at 83% of its 52-week range near $100, it shows strong momentum recovering from a sharp pullback, indicating investor confidence in the turnaround.
- Market Expects Earnings Recovery: The forward P/E of 33.99x is substantially lower than the trailing P/E of 52.58x, indicating the market is pricing in a significant earnings recovery over the next twelve months. Analyst estimates project an average EPS of $4.27, suggesting a return to more normalized profitability.
Bearish
- Severe Profitability & Margin Compression: Gross margin collapsed to 15.63% in the latest quarter from 27.91% in Q3 2024, and the net margin is just 4.99%. This severe compression, driven by the high costs of the operational turnaround, directly pressures earnings, with net income falling to $293.3 million from $780.8 million a year ago.
- Unsustainable Dividend Payout Ratio: The dividend payout ratio stands at an alarming 149.29%, meaning the dividend is not covered by current earnings. This puts the company's 15-year dividend growth streak at serious risk, as highlighted by recent news, creating a significant overhang for income-focused investors.
- Weak Balance Sheet & Liquidity: The balance sheet shows financial strain with a negative debt-to-equity ratio of -3.29 and a concerning current ratio of 0.72, indicating potential liquidity constraints. This limits financial flexibility and increases risk if the turnaround takes longer than expected or macro conditions worsen.
- Decelerating Revenue Growth: Revenue growth has slowed markedly to 5.43% year-over-year in the latest quarter, a significant deceleration from prior periods. This indicates a maturing top-line trajectory for the core business, raising questions about the company's ability to return to historical growth rates.
SBUX Technical Analysis
The stock is in a sustained uptrend, having gained 22.70% over the past year, and is currently trading at approximately 83% of its 52-week range, with a price of $100 relative to a 52-week high of $104.82 and low of $75.5. This positioning near the upper end of the range suggests strong momentum but also indicates the stock is approaching a key technical resistance level where profit-taking could emerge. Recent momentum has been robust and accelerating, with the stock up 7.92% over the past month and 7.54% over the past three months, significantly outperforming the S&P 500 (SPY) by 0.56% and 4.87% over those respective periods, signaling a strong recovery from a sharp pullback in late March. The 1-month surge has reinforced the longer-term uptrend, indicating the prior sell-off was a temporary correction within a broader bullish structure. Key technical support is anchored at the 52-week low of $75.5, while immediate resistance sits at the 52-week high of $104.82; a decisive breakout above $104.82 would signal a resumption of the primary bull trend, whereas a failure could lead to consolidation. With a beta of 0.944, the stock exhibits slightly lower volatility than the broader market, which, combined with a significant 1-year maximum drawdown of -21.07%, suggests it has experienced sharp but contained pullbacks, a factor for risk-aware investors to consider.
Beta
0.94
0.94x market volatility
Max Drawdown
-21.1%
Largest decline past year
52-Week Range
$76-$105
Price range past year
Annual Return
+20.2%
Cumulative gain past year
| Period | SBUX Return | S&P 500 |
|---|---|---|
| 1m | +8.2% | +8.5% |
| 3m | +2.0% | +2.8% |
| 6m | +15.6% | +4.6% |
| 1y | +20.2% | +32.3% |
| ytd | +18.5% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SBUX Fundamental Analysis
Revenue growth has been positive but has decelerated markedly, with the most recent quarterly revenue of $9.91 billion representing a year-over-year increase of 5.43%, a significant slowdown from the double-digit growth rates seen in prior comparable periods, indicating a maturing top-line trajectory. The company remains profitable with net income of $293.3 million in the latest quarter, but profitability metrics are under severe pressure, as evidenced by a trailing net margin of just 4.99% and a gross margin of 24.15%, which have compressed significantly from the 27.91% gross margin reported in Q3 2024, reflecting the high-cost environment of its operational turnaround. The balance sheet shows financial strain with a negative debt-to-equity ratio of -3.29 and a concerning current ratio of 0.72, indicating potential liquidity constraints; however, the company generated substantial trailing twelve-month free cash flow of $2.34 billion, providing a crucial buffer to fund operations and its dividend, though the payout ratio of 149.29% signals the dividend is not currently covered by earnings.
Quarterly Revenue
$9.9B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SBUX Overvalued?
Given that Net Income is positive ($293.3M in the latest quarter), the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 52.58x and a forward PE of 33.99x; the substantial gap between these multiples implies the market is pricing in a significant recovery in earnings over the next twelve months. Compared to sector averages, Starbucks trades at a premium; its forward PE of 33.99x is well above typical restaurant industry averages (often in the low-to-mid 20s), a premium that must be justified by a successful execution of its turnaround plan to restore historical margin levels and growth. Historically, the stock's own trailing PE has fluctuated widely, from lows around 20x to highs above 80x in recent quarters; the current trailing PE of 52.58x sits above its multi-year median, suggesting the market is already pricing in a substantial portion of the expected recovery, leaving limited room for multiple expansion unless execution exceeds expectations.
PE
52.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~184x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
22.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company's profitability is under severe pressure, with gross margin collapsing from 27.91% to 15.63% sequentially, and a net margin of just 4.99%. The dividend payout ratio of 149.29% is unsustainable, threatening its long-standing growth streak. Furthermore, the balance sheet shows liquidity constraints with a current ratio of 0.72 and a negative debt-to-equity ratio of -3.29, limiting financial flexibility. Revenue growth deceleration to 5.43% YoY adds to the operational challenges.
Market & Competitive Risks include a premium valuation that demands perfect execution. The forward P/E of 33.99x trades at a significant premium to typical restaurant industry averages, leaving little room for error. Competitive threats are evolving, as highlighted by news of Luckin's stakeholder acquiring Blue Bottle Coffee, signaling intensified competition in the premium segment. The stock's beta of 0.944 suggests it is not a defensive safe haven, and its 1-year maximum drawdown of -21.07% shows it is susceptible to sharp pullbacks during market stress or company-specific disappointments.
Worst-Case Scenario involves a failure of the turnaround to restore margins, leading to consecutive earnings misses, a dividend cut, and a loss of investor confidence in management's strategy. This could trigger multiple compression towards the sector average and a re-test of the 52-week low. From the current price of $100, a decline to the 52-week low of $75.5 would represent a loss of approximately -24.5%. A more realistic bear-case target in the low $80s, incorporating some residual premium for the brand, still implies a potential downside of -15% to -20%.
FAQ
The key risks are, in order of severity: 1) Financial Risk: An unsustainable dividend payout ratio of 149.29% and a weak current ratio of 0.72 threaten the dividend and liquidity. 2) Operational Risk: Severe gross margin compression to 15.63% pressures profitability, and the success of the costly turnaround is uncertain. 3) Competitive Risk: Intensifying competition from global players like Luckin/Blue Bottle and regional chains. 4) Growth Risk: Revenue growth has decelerated to 5.43% YoY, indicating maturation.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $90 and $100 as the turnaround progresses unevenly. The Bull Case (25% probability) targets $104 to $115 on successful margin recovery and sustained dividend. The Bear Case (20% probability) sees a drop to $75-$85 on a dividend cut or stalled recovery. The Base Case is most likely, predicated on the assumption that free cash flow remains strong enough to avoid a dividend cut while margins gradually improve.
SBUX is fairly valued relative to the recovery it must deliver, but overvalued if the turnaround fails. Its forward P/E of 33.99x commands a significant premium over the typical restaurant sector, justified only by its global brand and expected margin recovery. Historically, its own trailing P/E of 52.58x is above its median, suggesting the market is already pricing in improvement. The valuation implies the market expects a successful execution of the turnaround plan to restore net margins from the current 4.99% back towards historical levels.
SBUX is a conditional buy, suitable only for investors with a higher risk tolerance and a long-term horizon who have conviction in the brand's resilience. The current valuation (forward P/E of 33.99x) prices in a significant earnings recovery, offering limited margin of safety. The 22.7% one-year gain and position near 52-week highs suggest much optimism is already baked in. The biggest downside risk is a dividend cut, which could trigger a -15% to -20% decline. It is a good buy only for those who believe the turnaround will succeed and are willing to endure volatility.
SBUX is primarily suitable for a long-term investment horizon of 3-5 years, as the turnaround story will take multiple quarters to unfold. Its beta of 0.944 and history of sharp drawdowns (max -21.07%) make it volatile for short-term trading. The dividend, while at risk, provides some income for long-term holders if maintained. Given the binary nature of the current narrative and execution risk, a short-term trade is highly speculative. A minimum holding period of 12-18 months is suggested to assess the turnaround's initial results.